Characteristics of subjective cognitive decline associated with amyloid positivity

O. Janssen*, W.J. Jansen, S.J.B. Vos, M. Boada, L. Parnetti, T. Gabryelewicz, T. Fladby, J.L. Molinuevo, S. Villeneuve, J. Hort, S. Epelbaum, A. Lleo, S. Engelborghs, W.M. van der Flier, S. Landau, J. Popp, A. Wallin, P. Scheltens, M.O. Rikkert, P.J. SnyderC. Rowe, G. Chetelat, A. Ruiz, M. Marquie, E. Chipi, S. Wolfsgruber, M. Heneka, H. Boecker, O. Peters, J. Jarholm, L. Rami, A. Tort-Merino, A.P. Binette, J. Poirier, P. Rosa-Neto, J. Cerman, B. Dubois, M. Teichmann, D. Alcolea, J. Fortea, M.B. Sanchez-Saudinos, J. Ebenau, C. Pocnet, M. Eckerstrom, L. Thompson, V. Villemagne, R. Buckley, S. Burnham, M. Delarue, Y. Freund-Levi, Alzheimer's Disease Neuroimaging Initiative, FACEHBI study group, PREVENT-AD research group

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

Original languageEnglish
Number of pages14
JournalAlzheimer's & Dementia
DOIs
Publication statusE-pub ahead of print - 8 Dec 2021

Keywords

  • Alzheimer's disease
  • amyloid
  • cerebrospinal fluid
  • positron emission tomography
  • subjective cognitive decline
  • PRECLINICAL ALZHEIMERS-DISEASE
  • MEMORY COMPLAINTS
  • OLDER-ADULTS
  • DEMENTIA
  • POPULATION
  • RISK
  • COMMUNITY
  • PREVALENCE
  • DEPOSITION
  • SYMPTOMS

Cite this